BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 37178691)

  • 1. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
    Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
    Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSP1 is a glutathione-independent ferroptosis suppressor.
    Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
    Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase separation of FSP1 promotes ferroptosis.
    Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
    Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sabotaging the breaks: FSEN1 expands the toolbox of FSP1 inhibitors.
    Xavier da Silva TN; Friedmann Angeli JP
    Cell Chem Biol; 2023 Sep; 30(9):1006-1008. PubMed ID: 37738951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma.
    Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y
    Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance.
    Lee J; Roh JL
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance.
    Lin X; Zhang Q; Li Q; Deng J; Shen S; Tang M; Ye X; Ji C; Yang Y; Chen Y; Zeng L; Zhao J; Kouwenhoven MBN; Lucero-Prisno DE; Huang J; Li Y; Zhang B; Hu J
    Drug Resist Updat; 2024 Mar; 73():101032. PubMed ID: 38198846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
    Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional and Metabolic Control of Ferroptosis.
    Mishima E; Conrad M
    Annu Rev Nutr; 2022 Aug; 42():275-309. PubMed ID: 35650671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
    Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
    Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin Induces Ferroptosis in A549 CD133
    Zhou J; Zhang L; Yan J; Hou A; Sui W; Sun M
    Discov Med; 2023 Jun; 35(176):251-263. PubMed ID: 37272092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
    Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
    Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
    Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
    Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-targeted liposomal coenzyme Q10 attenuates neuronal ferroptosis after subarachnoid hemorrhage by activating the ferroptosis suppressor protein 1/coenzyme Q10 system.
    Peng Z; Ding YN; Yang ZM; Li XJ; Zhuang Z; Lu Y; Tang QS; Hang CH; Li W
    Acta Biomater; 2024 Apr; 179():325-339. PubMed ID: 38561074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1.
    Fan C; Guo X; Zhang J; Zheng W; Shi C; Qin Y; Shen H; Lu Y; Fan Y; Li Y; Chen L; Mao R
    Discov Oncol; 2024 Apr; 15(1):98. PubMed ID: 38565708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review.
    Liu M; Kong XY; Yao Y; Wang XA; Yang W; Wu H; Li S; Ding JW; Yang J
    Ann Transl Med; 2022 Mar; 10(6):368. PubMed ID: 35434035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of lipid peroxidation and ferroptosis in diverse species.
    Conrad M; Kagan VE; Bayir H; Pagnussat GC; Head B; Traber MG; Stockwell BR
    Genes Dev; 2018 May; 32(9-10):602-619. PubMed ID: 29802123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gongying-Jiedu-Xiji recipe promotes the healing of venous ulcers by inhibiting ferroptosis via the CoQ-FSP1 axis.
    Lu Y; Zhao D; Liu M; Cao G; Liu C; Yin S; Song R; Ma J; Sun R; Wu Z; Liu J; Wang Y
    Front Pharmacol; 2023; 14():1291099. PubMed ID: 38161691
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules.
    Xavier da Silva TN; Schulte C; Alves AN; Maric HM; Friedmann Angeli JP
    Cell Death Dis; 2023 Apr; 14(4):281. PubMed ID: 37080964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.